A study revealed that Medicaid beneficiaries with psoriasis experienced significant disparities in biologic treatment usage among different racial and ethnic groups from 2016 to 2022, with Black beneficiaries being less likely to use these treatments. This highlights a critical issue of unequal access to effective therapies based on race or ethnicity. Content creators should emphasize the importance of equitable healthcare access when discussing psoriasis management and biologic treatments.
Read the full article at MedPage Today
This is a brief trending article summary.
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



